Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 0 | 0 | 224 |
| Gross Profit | N/A | N/A | N/A | N/A | 224 |
| Operating Expenses | 24,821 | 21,354 | 5,711 | 4,090 | 3,964 |
| Operating Income | -24,821 | -21,354 | -5,711 | -4,090 | -3,740 |
| Interest Expense | 2,228 | 813 | 2,631 | 1,518 | 1,015 |
| Other Income | 1,835 | -5,110 | -6,790 | 473 | 315 |
| Pre-tax Income | -25,214 | -27,277 | -15,132 | -5,136 | -4,440 |
| Net Income Continuous | -25,214 | -27,277 | -15,132 | -5,136 | -4,440 |
| Net Income | $-25,214 | $-27,277 | $-15,132 | $-5,136 | $-4,440 |
| EPS Basic Total Ops | -4.17 | -5.71 | -4.48 | -5.97 | -11.94 |
| EPS Basic Continuous Ops | -2.84 | -5.54 | -5.01 | -5.45 | -12.58 |
| EPS Diluted Total Ops | -4.17 | -5.71 | -4.48 | -5.97 | -11.94 |
| EPS Diluted Continuous Ops | -2.84 | -5.54 | -5.01 | -5.45 | -12.58 |
| EPS Diluted Before Non-Recurring Items | -4.17 | -5.97 | -4.48 | -5.97 | -11.94 |
| EBITDA(a) | $-23,165 | $-20,396 | $-3,620 | $-3,414 | $-3,725 |